Literature DB >> 32980897

Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma.

Hai-Xia Gao1,2,3, Meng-Bo Wang4, Si-Jing Li1,2, Jing Niu1,2, Jing Xue1,2, Jun Li4, Xin-Xia Li5.   

Abstract

Peripheral T-cell lymphoma (PTCL) is a very aggressive and heterogeneous hematological malignancy and has no effective targeted therapy. The molecular pathogenesis of PTCL remains unknown. In this study, we chose the gene expression profile of GSE6338 from the Gene Expression Omnibus (GEO) database to identify hub genes and key pathways and explore possible molecular pathogenesis of PTCL by bioinformatic analysis. Differentially expressed genes (DEGs) between PTCL and normal T cells were selected using GEO2R tool. Gene ontology (GO) analysis and Kyoto Encyclopedia of Gene and Genome (KEGG) pathway analysis were performed using Database for Annotation, Visualization and Integrated Discovery (DAVID). Moreover, the Search Tool for the Retrieval of Interacting Genes (STRING) and Molecular Complex Detection (MCODE) were utilized to construct protein-protein interaction (PPI) network and perform module analysis of these DEGs. A total of 518 DEGs were identified, including 413 down-regulated and 105 up-regulated genes. The down-regulated genes were enriched in osteoclast differentiation, Chagas disease and mitogen-activated protein kinase (MAPK) signaling pathway. The up-regulated genes were mainly associated with extracellular matrix (ECM)-receptor interaction, focal adhesion and pertussis. Four important modules were detected from the PPI network by using MCODE software. Fifteen hub genes with a high degree of connectivity were selected. Our study identified DEGs, hub genes and pathways associated with PTCL by bioinformatic analysis. Results provide a basis for further study on the pathogenesis of PTCL.

Entities:  

Keywords:  bioinformatic analysis; hub genes; pathways; peripheral T-cell lymphomas; protein-protein interaction

Mesh:

Substances:

Year:  2020        PMID: 32980897     DOI: 10.1007/s11596-020-2250-9

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  53 in total

Review 1.  Peripheral T-cell lymphoma.

Authors:  Francine M Foss; Pier Luigi Zinzani; Julie M Vose; Randy D Gascoyne; Steven T Rosen; Kensei Tobinai
Journal:  Blood       Date:  2011-04-14       Impact factor: 22.113

2.  Crizotinib in anaplastic large-cell lymphoma.

Authors:  Carlo Gambacorti-Passerini; Cristina Messa; Enrico M Pogliani
Journal:  N Engl J Med       Date:  2011-02-24       Impact factor: 91.245

Review 3.  Molecular classification of T-cell lymphomas.

Authors:  Laurence de Leval; Bettina Bisig; Caroline Thielen; Jacques Boniver; Philippe Gaulard
Journal:  Crit Rev Oncol Hematol       Date:  2009-02-23       Impact factor: 6.312

Review 4.  From empiric to mechanism-based therapy for peripheral T cell lymphoma.

Authors:  Andrew M Intlekofer; Anas Younes
Journal:  Int J Hematol       Date:  2014-02-08       Impact factor: 2.490

Review 5.  The spectrum of peripheral T-cell lymphomas.

Authors:  Hilary O'leary; Kerry J Savage
Journal:  Curr Opin Hematol       Date:  2009-07       Impact factor: 3.284

Review 6.  Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?

Authors:  J J Scarisbrick; Y H Kim; S J Whittaker; G S Wood; M H Vermeer; H M Prince; P Quaglino
Journal:  Br J Dermatol       Date:  2014-06       Impact factor: 9.302

Review 7.  The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.

Authors:  James O Armitage
Journal:  Am J Hematol       Date:  2012-05       Impact factor: 10.047

8.  Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.

Authors:  Steven M Horwitz; Ranjana H Advani; Nancy L Bartlett; Eric D Jacobsen; Jeff P Sharman; Owen A O'Connor; Tanya Siddiqi; Dana A Kennedy; Yasuhiro Oki
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

9.  PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.

Authors:  Esperanza Martín-Sánchez; Lina Odqvist; Socorro M Rodríguez-Pinilla; Margarita Sánchez-Beato; Giovanna Roncador; Beatriz Domínguez-González; Carmen Blanco-Aparicio; Ana M García Collazo; Esther González Cantalapiedra; Joaquín Pastor Fernández; Soraya Curiel del Olmo; Helena Pisonero; Rebeca Madureira; Carmen Almaraz; Manuela Mollejo; F Javier Alves; Javier Menárguez; Fernando González-Palacios; José Luis Rodríguez-Peralto; Pablo L Ortiz-Romero; Francisco X Real; Juan F García; James R Bischoff; Miguel A Piris
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

10.  NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.

Authors:  Joel D Pearson; Jason K H Lee; Julinor T C Bacani; Raymond Lai; Robert J Ingham
Journal:  J Signal Transduct       Date:  2012-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.